Search clinical trials for: Org 36286

Total 6089 results

Organon and Co

Completed

Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)

Infertility
Organon and Co

Completed

A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788) (Realize)

In Vitro Fertilization
University of Aarhus
Aarhus University Hospital Skejby; Department of Microbiological Surveillance...

Completed

A Pharmacokinetic and Pharmacodynamic Study of Phenoxymethylpenicillin for Children

Phenoxymethylpenicillin

Denmark
Organon and Co

Completed

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) (Ensure)

Infertility
Organon and Co

Completed

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714) (Trust)

In Vitro Fertilization
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783) (Care)

Pregnancy | Neonates
Organon and Co

Completed

Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)

Pregnancy | Neonates
Organon and Co

Completed

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

Fertilization
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715) (Care)

Pregnancy | Neonates
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)

Pregnancy
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713) (Care)

Pregnancy | Neonates
Organon and Co

Completed

Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029) (PURSUE)

Infertility
Organon and Co

Completed

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

Infertility | In Vitro Fertilization
Ulrich Mehnert
Institut Guttmann; Schweizerisches Paraplegikerzentrum Nottwil; BG Unfallklinik... and other collaborators

Withdrawn

Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients

Spinal Cord Injury | Neurogenic Detrusor Overactivity

Switzerland, Spain
Organon and Co

Terminated

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

Ovulation Induction
Organon and Co

Completed

An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)

Infertility
Organon and Co

Completed

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

In Vitro Fertilization
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Leukemia

Canada, United States
National Taipei University of Nursing and Health...

Recruiting

The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia

Dementia

Taiwan
Organon and Co

Completed

A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

In Vitro Fertilization
Weill Medical College of Cornell University

Completed

Safety Study of ORG 34517 for Major Depression With Psychotic Features

Psychotic Disorders | Major Depressive Disorder

United States
Abbott Medical Devices

Not yet recruiting

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) (XANADO)

Chronic Pain

United States
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845) (Hermes)

Depression | Psychotic Disorders | Depressive Disorders
Origo Biopharma

Completed

First in Human Study of ORG-129 in Healthy Volunteers

Healthy Volunteers

Spain
Guangzhou General Hospital of Guangzhou Military...
Guangdong Provincial Hospital of Traditional Chinese Medicine

Recruiting

Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation

Pharmacokinetics

China
Merck Sharp & Dohme LLC

Completed

A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

Psychosis
Merck Sharp & Dohme LLC

Completed

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Depression | Psychotic Disorders | Depressive Disorders
Dennis Charney
National Institutes of Health (NIH)

Withdrawn

Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder

Major Depressive Disorder
Merck Sharp & Dohme LLC

Terminated

Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)

Panic Disorder
Merck Sharp & Dohme LLC

Completed

Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)

Anesthesia
Merck Sharp & Dohme LLC

Completed

Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)

Anesthesia, General
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

Neuroblastoma

United States, Canada, Australia
Guangzhou General Hospital of Guangzhou Military...

Recruiting

Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery

Pharmacokinetics

China
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934)

Anesthesia
Sidney Kimmel Cancer Center at Thomas Jefferson...
NovoCure Ltd.

Completed

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Glioblastoma

United States
Merck Sharp & Dohme LLC

Completed

Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)

Anesthesia, General
Merck Sharp & Dohme LLC

Completed

Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) (GIANT)

Schizophrenia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Brain Tumor | Central Nervous System Tumor

United States
University of Plymouth
Veeda Clinical Research; Organon Teknika

Completed

First Administration to Man Of Org 25435 a New Intravenous Anesthetic

Anaesthesia

United Kingdom
Universidad El Bosque, Bogotá
Gloria Lafaurie; Carlos Leal

Completed

Horizontal Ridge Augmentation in Mandible Usign ROG + ESWT

Bone Regeneration

Colombia
Washington University School of Medicine
The Craig H. Neilsen Foundation

Completed

Motor Learning Approach for Manual Wheelchair Users

Spinal Cord Injuries

United States
Merck Sharp & Dohme LLC

Completed

Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)

Anesthesia, General
Guangzhou General Hospital of Guangzhou Military...

Recruiting

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Brain Tumors

China
National Institute of Mental Health (NIMH)

Terminated

Org 24448 to Treat Major Depression

Depression

United States
Guangzhou General Hospital of Guangzhou Military...

Unknown

Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade

Pharmacokinetics | Pharmacodynamics

China
Merck Sharp & Dohme LLC

Completed

A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956)

Anesthesia, General
Orion Corporation, Orion Pharma

Completed

Early Phase I Microdosing Study of ORM-14540 and ORM-12741

Healthy

Finland
Organon and Co
CRS Mannheim GmbH

Completed

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

Healthy
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of 4.0 mg/kg Sugammadex at 1-2 PTC in Chinese and European Subjects (Study 19.4.335)(P05775AM1)(COMPLETED)

Anesthesia, General | Neuromuscular Blockade

3

Subscribe